Sector pending / Electromedical and Electrotherapeutic ApparatusUpdated 2026-05-10 22:07 UTC

FRA/6L8 stock hub

FRA/6L8 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/6L8is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.1B

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/6L8FRA/6L8

—

Loading chart…

In the news

Latest news · FRA/6L8

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-80.7

P25 n/aP50 n/aP75 n/a

ROIC-48.3

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/6L8 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

142

Groups with data

Currency

USD

Showing 142 of 142 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	116
Employees Change	19%
Employees Change Percent	33.93
Enterprise value	EUR 1.1B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Electromedical and Electrotherapeutic Apparatus
Last refreshed	2026-05-10
Market cap	EUR 1.1B
Price	EUR 16.5
Price currency	EUR
Rev Per Employee	5,615.02x
Sic	3845
Symbol	fra/6L8
Website	https://www.pulsebiosciences.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-5.85%
EV Earnings	-16.3x
P/B ratio	19.23x
P/S ratio	1,697.96x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	-21.04%
Gross Profit	EUR -137,033
Net Income	EUR -64.7M
Pretax Margin	-9,929.03%
Profit Per Employee	EUR -557,517
ROA	-45.03
Roa5y	-51.24
ROCE	-107.8
ROE	-80.72
Roe5y	-181.9
ROIC	-48.29

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	13.8%
Cagr3y	28.64%
Cagr5y	3.19%
Revenue Growth3 Y	43.15x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.01
Assets	EUR 70.8M
Cash	EUR 59.3M
Current Assets	EUR 60.3M
Current Liabilities	EUR 8.3M
Debt	EUR 6.2M
Debt Equity	EUR 0.11
Equity	EUR 57.5M
Liabilities	EUR 13.3M
Long Term Assets	EUR 10.5M
Long Term Liabilities	EUR 5M
Net Cash	EUR 53M
Net Cash By Market Cap	EUR 4.8
Net Cash Growth	-44.75%
Net Debt Equity	EUR -0.92
Tangible Book Value	EUR 54.7M
Tangible Book Value Per Share	EUR 0.8

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.26
Inventory Turnover	7.7
Net Working Capital	EUR -4.6M
Quick ratio	6.99
Working Capital	EUR 53.2M
Working Capital Turnover	EUR 0.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-11.03%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	13.79%
200-day SMA	14.59
3Y total return	112.9%
50-day SMA	17.68
50-day SMA vs 200-day SMA	50over200
5Y total return	17.02%
All Time High	38.8
All Time High Change	-57.47%
All Time High Date	2021-02-08
All Time Low	1.21
All Time Low Change	1,263.64%
All Time Low Date	2022-08-30
ATR	0.72
Ch YTD	39.83
High	16.5
High52	21.4
High52 Date	2026-02-19
High52ch	-22.9%
Low	16.5
Low52	10.8
Low52 Date	2025-11-21
Low52ch	52.78%
Ma50ch	-6.65%
Price vs 200-day SMA	13.09%
RSI	42.5
RSI Monthly	57.52
RSI Weekly	51.63
Sharpe ratio	0.45x
Sortino ratio	0.97
Total Return	-11.03%
Tr YTD	39.83
Tr1m	-15.82%
Tr1w	-5.71%
Tr3m	39.83%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -67.2M
Operating margin	-10,313.6

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	18,029,911%
Shares Insiders	72.65%
Shares Institutions	9.26%
Shares Qo Q	0.3%
Shares Yo Y	11.03%
Short Ratio	9.06

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	51.1x
Bv Per Share	0.84
Ch1m	-15.82
Ch1w	-5.71
Ch1y	13.79
Ch3m	39.83
Ch3y	112.9
Ch5y	17.02
Ch6m	23.13
Change	1.85%
Change From Open	0
Close	16.2
Days Gap	1.85
Depreciation Amortization	895,235.9
Earnings Date	2026-08-10
EBIT	EUR -67.2M
EBITDA	EUR -66.3M
EPS	EUR -0.96
F Score	0
Fiscal Year End	December
Founded	2,014
Goodwill	2,366,661.9
Is Primary Listing	0
Last Earnings Date	2026-02-19
Last Report Date	2026-03-31
Ma150	15.01
Ma150ch	9.95%
Ma20	17.84
Ma20ch	-7.51%
Next Earnings Date	2026-08-10
Open	16.5
Ppne	5,696,608.7
Price Date	2026-05-08
Ptbv Ratio	20.21
Relative Volume	0.59x
Revenue	651,342x
Tr6m	23.13%
Volume	0
Z Score	33.38

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/6L8 pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/6L8 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/6L8?

Insider, institutional, and short-interest positioning.

Institutional ownership

+9.3%

Share of float held by funds and institutions

Insider ownership

+72.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/6L8 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

42.5

Neutral momentum band

Price vs 200-day MA

+13.1%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.45

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/6L8

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/6L8 stock rating?

fra/6L8 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/6L8 analysis?

The full report lives at /stocks/fra/6L8/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/6L8?

The latest report frames fra/6L8 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/6L8 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.